2023 markets outlook & buyside picks
Industry remains in survival mode but catalysts abound
Chk out FREE podcast here (or on Apple, Stitcher, Google, etc):
Follow
matt krebs
@krebs_matt
matt krebs’s Tweets
Chk out s latest data-byte:
Series A funding remained strong in 2022
Details and analysis here (sub/trial access required):
biocentury.com/article/646564
2
1. BioCentury This Week Podcast
2. Biotech 2050 Podcast
3. Business of Biotech
4. Cell & Gene The Podcast
5. Rx for Biotech Podcast
Show this thread
Top 5 Life Science Podcasts You Need to Listen To!
#1 This Week Podcast
Thank you !
1
3
Show this thread
Our CSO, Tony Wood, joined Editor in Chief for a discussion on our approach to R&D, including our focus on areas like #infectiousddiseases.
Register for free access: gsk.to/3FVGlg0
#pharma #oncology #researchanddevelopment #thebiocenturyshow
6
6
Missed this. Taylor Swift was seen at BTIG's #ASH22 party on Saturday night. Yes, that's really her. No kidding.
Quote Tweet
Running into Taylor Swift at the BTIG event is certainly a highlight of #ASH22.
10
9
80
Show this thread
MUST READ from
#ASH22 could be IL-18’s watershed moment
[Details/analysis via subscription or free trial access]:
1
3
ABSOLUTE MUST LISTEN TO WEBCAST from
Talk to us early and often, but deals take time, says
's Sabry
Details and analysis here (FREE with registration):
3
2
From the "way back machine".
Have a look webcasts from 9 yrs ago vs today!
youtube.com/watch?v=CCKX8d (9 yrs ago)
biocentury.com/article/645713 (today)
3
4
. on YouTube? What?
Deets:
Optimism vs obstacles: Volkow sees potential for progress on addiction d... youtu.be/sixHZ6F9aHw via
5
LG’s Aveo acquisition a rare case of a Korean biotech buying a U.S. biotech
Details and analysis in here:
2
Preclinical IPO companies don’t stay preclinical for long
Detail & analysis here
6
ICYMI:
A Data Byte on
"The mRNA therapeutics pipeline"
Details and analysis here (sub/trial access required):
4
BIO places CEO McMurry-Heath on leave
Details and analysis here in
(sub/trial access required):
1
2
WOW!
Companies founded by Nobel Prize winner
Details in here in BioCentury: biocentury.com/article/645405
6
Congrats to my former bandmate on her in chemistry! We won the Ivy League Battle of the Bands in 1986 with our rockin’ group ‘Bored Of Education’, with her on keyboards & me in spandex.
196
4,528
28.4K
Ever have one of those days where you just needed some good news, and found it unexpectedly? I don’t often go to the NYT for good news. But man, this made me Smile!!! N I’m not even a Yankees fan!
With His 62nd Home Run, Aaron Judge Makes His Case
7
Many thanks to for the comprehensive coverage of . Great summary of who we are and what we do. Also huge thx to , and for their participation and unwavering support.
1
7
11
Janssen’s first AAV programs remain in play with AAO readouts
Details and analysis
2
Amylyx approval gives reason for optimism across #neurodegeneration
's Selina Koch dives into the details here: (Sub/trial access required):
3
Interesting Deal!
ArsenalBio and Genentech scaling up search for T cell levers
Deets
3
"A suite of liquid biopsy approaches for cancer detection & more"
Chk out ’s roundup of translational news here (trial/sub access required):
Wish all pollical campaigns ended like this! 2 years old now, but I dont get tired of watching it.
We Approve youtu.be/3is3gZP50oY via
3
Looking for emerging #biotech cos with next gen platforms? Chk out . E.g. Hot off the presses:
Triana: Molecular glues for degradation and beyond
3
You can find this data here: biocentury.com/bciq-data/fina
Quote Tweet
Here's a look at YoY comparison for Money Raised in the #biotech industry.
I'm taking a glass-is-half-full look at this: never been a better time to invest in biotech?
4
Here's a look at YoY comparison for Money Raised in the #biotech industry.
I'm taking a glass-is-half-full look at this: never been a better time to invest in biotech?
1
2
3
2
Awesome view of St. Patrick’s Cathedral from my window at the Cantor conference earlier today.
5
5
107
Didnt realize how popular our FREE podcast was until recently! I have trouble finding folks that haven't been listening.
You can listen on usual suspects, like:
Apple: podcasts.apple.com/us/podcast/bio
Spotify:
open.spotify.com/show/3bh608DbM
And our site...
1
2
8
Chinese investigator-initiated trials are accelerating CAR T innovation, bringing solid tumor advances to #ESMO22. via 's biocentury.com/article/645086
5
7
The IRA has fundamentally reset the economics of drug development, CEO Ricks told . Value of most small molecules halved. Some drugs won’t be developed, value of some biotechs crushed. More ($) at biocentury.com/article/645009.
4
29
65
MUST READ:
"Inflation act has slashed value of small molecules"
CEO warns effects of Inflation Reduction Act will ripple through biopharma ecosystem
Details & analysis ONLY available (Sub/trial access required):
1
Over 400 women are CEOs of biotech companies said . 62% are in US, 29% in Europe, 8% Asia-Pacific, & only 1% in Canada. 57% became CEO in the past 5 yrs. 40% were both founders & 1st-time CEOs. 22% are public companies. Story by
6
13
#BioCenturyBackToSchool2022 includes an analysis of women biopharma CEOs, presenting the finding that there are over 400 female-led biopharma companies and exploring the paths women have forged to get to the top. (no paywall) biocentury.com/article/644820
1
10
10
The new modality pipeline against ANGPTL3 grows with Verve’s new program
Details and analysis you can ONLY find (sub/trial access required):
biocentury.com/article/644886
5